Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Niemann-Pick Disease (NPD) Market Expected To Grow In Terms Of Size?

In recent times, there has been a significant surge in the size of the niemann-pick disease (npd) market. It is predicted to expand from $0.97 billion in 2024 to $1.07 billion in 2025, experiencing a compound annual growth rate (CAGR) of 10.0%. The past growth can be linked to several factors such as escalating numbers of genetic counselors, expanding financial support for rare disease research, a rise in venture capital firm investments, surging biomarker usage, and wider healthcare accessibility.

Expectations for the Niemann-Pick disease (NPD) market show a swift increase in the coming years. The market is projected to reach $1.62 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 11.0%. This growth during the prediction period can be credited to the rising demand for personalized medicine and an increased focus on lysosomal storage disorders, along with the approval of more orphan drugs and a surge in demand for targeted treatments and advanced diagnostic tools. Notable developments during this forecast period encompass improvements in treatment choices, technological upgrades in diagnostic equipment, the incorporation of artificial intelligence into diagnosis procedures, advancements in enzyme replacement therapies (ERT), and the progression of clinical trials for new medical drugs.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23457&type=smp

What Are The Primary Factors Supporting The Niemann-Pick Disease (NPD) Market Expansion?

The expansion of the Niemann-Pick disease (NPD) market is likely due to increased acceptance of gene therapy. As a method of medical treatment, gene therapy alters or manages an individual’s genes to fight or avoid disease. Due to progressive techniques like in situ haploid, which allows detailed and efficient genetic adjustments, it is becoming more common, leading to improved results for genetically based conditions. Gene therapy, by addressing root genetic mutations in Niemann-Pick disease (NPD), aims to rectify enzyme deficiencies causing the disorder and enhancing cell function. For instance, the American Society of Gene and Cell Therapy reported a 10% increase in Phase III trials of gene therapies in January 2024 compared to the preceding quarter, marking the first rise since the third quarter of 2022. Consequently, the Niemann-Pick disease (NPD) market’s growth can be attributed to the broader implementation of gene therapy.

Which Segmentation Categories Are Highlighted In The Niemann-Pick Disease (NPD) Market Analysis?

The niemann-pick disease (npd)market covered in this report is segmented –

1) By Type: Niemann-Pick Disease Type A; Niemann-Pick Disease Type B; Niemann-Pick Disease Type C

2) By Treatment Type: Drugs; Physical Therapy; Other Treatment Types

3) By Route Of Administration: Oral; Intravenous; Subcutaneous

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels

5) By End-User: Hospitals; Clinics; Homecare Settings

Subsegments:

1) By Niemann-Pick Disease Type A: Infantile-Onset Niemann-Pick Disease; Neurodegenerative Niemann-Pick Disease; Acute Visceral Niemann-Pick Disease; Severe Lysosomal Storage Disorder

2) By Niemann-Pick Disease Type B: Late-Onset Niemann-Pick Disease; Non-Neurological Niemann-Pick Disease; Chronic Visceral Niemann-Pick Disease; Mild Lysosomal Storage Disorder

3) By Niemann-Pick Disease Type C: Early-Onset Niemann-Pick Disease; Juvenile Niemann-Pick Disease; Adult-Onset Niemann-Pick Disease; Progressive Neurodegenerative Niemann-Pick Disease

Which Trends Are Likely To Redefine Growth Paths In The Niemann-Pick Disease (NPD) Market?

Prominent corporations in the niemann-pick disease (NPD) market are concentrating on the advancement of innovative treatments such as combination therapy, aiming to increase treatment effectiveness and elevate patient prognosis. The combination therapy approach comprises administering two or more therapeutic substances or treatment approaches to combat an illness or health condition. This technique is designed to enhance efficacy and diminish resistance to therapy using a single agent (monotherapy). For example, in September 2024, Zevra Therapeutics Inc., a biopharmaceutical firm based in the US, secured approval from the U.S. Food and Drug Administration (FDA) for MIPLYFFA, a treatment used in combination with miglustat, to cure neurological symptoms of Niemann-Pick disease type C (NPC) in adults and children aged 2 years and above. MIPLYFFA (arimoclomol) operates by amplifying the generation of heat shock proteins (HSPs), which play a crucial role in removing harmful lipid buildup and safeguarding neurons from impairment. Concurrently, miglustat curbs glucosylceramide synthase, thus decreasing lipid accumulation. Combined, these two therapies contribute to decelerating the deterioration of neurological function in NPC patients.

Which Organizations Are At The Forefront Of The Niemann-Pick Disease (NPD) Market?

Major companies operating in the niemann-pick disease (NPD) market are Sanofi S.A., Mayo Clinic, Cincinnati Children’s Hospital Medical Center, Boston Children’s Hospital, Mallinckrodt Pharmaceuticals plc, Myriad Genetics, CENTOGENE N.V., The Florey Institute of Neuroscience and Mental Health, National Organization for Rare Disorders (NORD), Evox Therapeutics Limited, Zevra Therapeutics Inc., IntraBio Inc., Dipharma SA, Okklo Life Sciences, Bloomsbury Genetic Therapies Ltd., Azafaros A.G, Cyclo Therapeutics Inc., Mandos Health, CarelonRx, Rainbow Children’s Hospital, Vtesse Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/niemann-pick-disease-npd-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Niemann-Pick Disease (NPD) Market?

North America was the largest region in the niemann-pick disease (NPD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the niemann-pick disease (NPD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=23457&type=smp

Browse Through More Reports Similar to the Global Niemann-Pick Disease (NPD) Market 2025, By The Business Research Company

Brain Monitoring Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-monitoring-global-market-report

Brain Computer Interface Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-computer-interface-global-market-report

Brain Health Supplements Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-health-supplements-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model